Johnson & JohnsonJNJ

J&J's pharma and device units rely on bioprocessing and contract-manufacturing suppliers.

View stock

Theme · Pharma + medtech

Where the cash goes~$31B / yr · FY2025

R&D$15B

Dividends$11.8B

Capex$4.5B

Money flows left → right · hover a node · click to open the stock.ManufacturingComponents

Most exposed to JNJ's spend

Thermo FisherTMOCurated
Bioprocessing and lab services.
Manufacturing
DanaherDHRCurated
Filtration and diagnostics tools.
Manufacturing
CatalentCTLTCurated
Contract manufacturing.
Manufacturing
West PharmaceuticalWSTCurated
Delivery components.
Components

Relationships are hand-curated and sourced from filings, announcements, and public reporting — a map for generating ideas, not a complete supply chain, and not investment advice. Exposure weights are relative, for sizing only. Spot something missing? Contributions welcome on GitHub.